Manual vs Automated Anesthesia : Impact On The Incidence Of POCD
Manual vs Automated Optimization of Anesthesia, Analgesia, Fluid Management and Ventilation Using Closed-loop Systems: Impact On The Incidence Of POCD In Elderly Patients Undergoing Moderate to High Risk Surgery
1 other identifier
interventional
90
1 country
1
Brief Summary
This study will be the first study to report the combined use of three independent closed-loop systems together to assist clinicians in titrating anesthesia, analgesia, fluid and optimize ventilation in frailty old patients undergoing moderate to high risk surgery. The potential benefits of optimizing the control of these variables by advanced closed loop systems are two-fold. Firstly, this will likely decrease the variance of delivered care and reduce deviation from the established standards, resulting in improved post operative cognitive outcomes in elderly patients. Secondly, this would establish a precedent that automated intraoperative systems have strong clinical significance and are more than "complicated toys", which is unfortunately how they are perceived now. Hypothesis: Automated control of anesthetic depth (minimal episodes of overly deep or light anesthesia) and hemodynamics (via improved volume administration) can decrease the occurrence of postoperative cognitive dysfunction in elderly patients undergoing moderate to high risk surgery (Better MOCA test in the postoperative period compared to the manual group \[+ two points in average\])
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 1, 2017
CompletedStudy Start
First participant enrolled
May 10, 2017
CompletedFirst Posted
Study publicly available on registry
May 11, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 21, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 21, 2017
CompletedJanuary 28, 2020
January 1, 2020
7 months
May 1, 2017
January 26, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of postoperative cognitive dysfunction (POCD)
assessment of the POCD using the MOCA test ( done by a psychiatrist and a psychologist). This will be done preoperatively, at postoperative day 3-5 for moderate risk surgery and postoperative day 7-10 for high risk surgery
first month
Secondary Outcomes (19)
Assesment of the incidence of POCD using different others tests:
Before Surgery
Assesment of the incidence of POCD using different others tests:
day 5 after surgery
Assesment of the incidence of POCD using different others tests:
day 10 after surgery
Long term incidence of POCD
month 3 post surgery
Assessment of the Quality of life EQ-5D-5L
3 months
- +14 more secondary outcomes
Study Arms (2)
manual group
NO INTERVENTIONThis group will have a standard of care anesthesia. All the drugs, fluid and adjustement of ventilation settings will be done manually by the supervising anesthesiologist using the same drugs and fluids as the closed-loop group
automated closed-loop group
EXPERIMENTALThis group will have a fully automated anesthesia, analgesia , ventilation and fluid management using 3 indenpendent closed-loop systems same drugs used in both groups ( propofol and remifentanil, Plasmalyte and /or Voluven)
Interventions
Use of 3 indenpendent closed-loop systems to deliver the propofol, remifentanil, fluid and to adjust ventilation
Eligibility Criteria
You may qualify if:
- Adult patients \> or equal 60 years old
- ASA score I-III
- Scheduled for non cardiac surgery under total intravenous anesthesia
- Self sufficient (living at home or in non medical institution)
- MOCA test preop \> 23/30
- No Stroke, alzeihmer, Parkinson disease
- Written informed consent signed
You may not qualify if:
- Allergy to propofol or remifentanil
- MOCA test \< 23/30
- Visual or hearing deficiency
- Atrial fibrillation, or other Contra indication to the use of dynamic parameters of fluid responsiveness.
- Chronic renal failure ( creatinin level maximum at 2 mg/ml; no dialysis)
- Large liver resection : our center has a strict fluid /CVP fluid restriction in place
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Erasme
Brussels, 1070, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alexandre Joosten, M.D
Erasme
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- single blinded ( outcome assessor)
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 1, 2017
First Posted
May 11, 2017
Study Start
May 10, 2017
Primary Completion
November 21, 2017
Study Completion
November 21, 2017
Last Updated
January 28, 2020
Record last verified: 2020-01